Structure Therapeutics Inc. held its Annual General Meeting of Shareholders on June 23, 2025. Eric Dobmeier and Joanne Waldstreicher, M.D. were elected as Class II directors. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Shareholders approved the advisory vote on the preferred frequency of shareholder advisory votes on executive compensation to occur every year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.